Literature DB >> 4973067

Yellow fever virus. I. Development and evaluation of a plaque neutralization test.

S Spector, N M Tauraso.   

Abstract

Heretofore, the most reliable way of measuring yellow fever virus antibody was to use the mouse neutralization (MN) test employing either suckling or weanling mice. Certain disadvantages (e.g., expense both of animals and of maintaining a mouse colony, allergic reactions of many laboratory workers, and the relatively long time, 21 days, before end points are reached) are inherent in any program with mice or other laboratory animal species and have discouraged the use of the MN test by many laboratories. A previously reported plaque neutralization (PN) test with primary chick embryo cell cultures could not be consistently reproduced by later investigators. We have developed a convenient and reproducible PN test employing the MA-104 embryonic rhesus monkey kidney cell culture and a single agar-overlay procedure. When compared with MN tests with newborn (1 to 3 days old) and weanling (16 to 20 g, 24 to 28 days old) mice inoculated by the intracranial route, the PN test was the most sensitive for measuring neutralizing antibody; it was also less variable, less costly, and it achieved results in the shortest period of time. End points could be determined in 5 to 6 days for the PN test as compared to 21 days for the MN test.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4973067      PMCID: PMC547757          DOI: 10.1128/am.16.11.1770-1775.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  Arthropod-borne virus plaques in agar overlaid tube cultures.

Authors:  J R HENDERSON; R M TAYLOR
Journal:  Proc Soc Exp Biol Med       Date:  1959-06

2.  Plaque production with yellow fever and related arthropodborne viruses.

Authors:  J S PORTERFIELD
Journal:  Nature       Date:  1959-04-11       Impact factor: 49.962

3.  PROTECTION AGAINST JUNIN VIRUS BY IMMUNIZATION WITH LIVE TACARIBE VIRUS.

Authors:  N TAURASO; A SHELOKOV
Journal:  Proc Soc Exp Biol Med       Date:  1965-07

4.  Plaque assay of dengue and other group B arthropod-borne viruses under methyl cellulose overlay media.

Authors:  I T SCHULZE; R W SCHLESINGER
Journal:  Virology       Date:  1963-01       Impact factor: 3.616

5.  A plaque technique for the titration of yellow fever virus and antisera.

Authors:  J S PORTERFIELD
Journal:  Trans R Soc Trop Med Hyg       Date:  1959-11       Impact factor: 2.184

6.  Propagation of certain arthropod-borne viruses in avian and primate cell cultures.

Authors:  J R HENDERSON; R M TAYLOR
Journal:  J Immunol       Date:  1960-06       Impact factor: 5.422

7.  A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS.

Authors:  H Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  1960-08       Impact factor: 11.205

8.  SUSCEPTIBILITY OF WHITE MICE TO THE VIRUS OF YELLOW FEVER.

Authors:  M Theiler
Journal:  Science       Date:  1930-04-04       Impact factor: 47.728

9.  Yellow fever vaccine. I. Development of a vaccine seed free from contaminating avian leukosis viruses.

Authors:  N M Tauraso; S L Spector; W G Jahnes; A Shelokov
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

10.  Plaque formation and isolation of pure lines with poliomyelitis viruses.

Authors:  R DULBECCO; M VOGT
Journal:  J Exp Med       Date:  1954-02       Impact factor: 14.307

  10 in total
  17 in total

1.  Yellow fever vaccine seroconversion in travelers.

Authors:  Allison Kay; Lin H Chen; Maggie Sisti; Thomas P Monath
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

Review 2.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

3.  Yellow fever vaccine. 3. Antibody response in monkeys inoculated with a vaccine free from contaminating avian leukosis viruses.

Authors:  N M Tauraso; S L Spector; R W Trimmer
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Heat-labile accessory factor involved in vaccinia virus plaque neutralization.

Authors:  T C O'Brien; J E Hannah; N M Tauraso
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine.

Authors:  R A Mason; N M Tauraso; R O Spertzel; R K Ginn
Journal:  Appl Microbiol       Date:  1973-04

6.  Yellow fever vaccine. V. Antibody response in maonkeys inoculated with graded doses of the 17D vaccine.

Authors:  R A Mason; N M Tauraso; R K Ginn; T C O'Brien; R W Trimmer
Journal:  Appl Microbiol       Date:  1972-05

7.  Problems in the laboratory isolation of simian hemorrhagic fever viruses and isolatse metaboli enterobacteriaceae classificat enterobacteriaceae enzymology hydrogen peroxide metaboli enterobacteriaceae metaboliion of the agent responsible for the Sussex-69 epizootic.

Authors:  M G Myers; M M Vincent; S A Hensen; N M Tauraso
Journal:  Appl Microbiol       Date:  1972-07

8.  Vaccinia virus: kinetics of the hemagglutination-inhibition test and preparation of hemagglutinin.

Authors:  T C O'Brien; N M Tauraso
Journal:  Arch Gesamte Virusforsch       Date:  1972

9.  Kinetics of the vaccinia virus plaque neutralization test.

Authors:  T C O'Brien; M G Myers; N M Tauraso
Journal:  Appl Microbiol       Date:  1971-05

10.  Yellow fever virus. II. Factors affecting the plaque neutralization test.

Authors:  S L Spector; N M Tauraso
Journal:  Appl Microbiol       Date:  1969-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.